Previous cost of control analyses published in the US setting for GLP-1 receptor agonists once-weekly semaglutide and liraglutide have demonstrated the value of the cost of control approach, offering pertinent information to healthcare payers focused on short-term budgets [14,15,16,17]
Ozempic Babies: Weight Loss Drugs May be Causing Unplanned Pregnancies (healthline.com)
[9] Whilst these effects support glycaemic control and weight reduction, they also present a nutritional challenge: reduced food intake can inadvertently lead to inadequate protein consumption
2008 Dec 1;76(11):1485-9
37 Giri TK, Newton D, Chaudhary O, Deych E, Napoli N, Villareal R, Diemer K, Milligan PE, Gage FB